Pseudoprogression Possible in Enzalutamide-Treated mCRPC – Renal and Urology News
In mCRPC, pseudoprogression or bone scan flare can be misinterpreted as enzalutamide failure and lead to premature discontinuation of therapy.
In mCRPC, pseudoprogression or bone scan flare can be misinterpreted as enzalutamide failure and lead to premature discontinuation of therapy.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence…
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence…
Become an AUA member and SAVE up to $886 on Annual Meeting registration!
This Guideline is intended for clinicians evaluating and managing male chronic pelvic pain. The following conditions are covered in this Guideline: (i) chronic prostatitis/ chronic…
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence…
This is a call for younger AUA members to polish their leadership skills, take advantage of networking opportunities and become better acquainted with AUA programs…
Join the AUA Residents and Fellows Committee for the largest gathering of residents at the Annual Meeting. This year’s Forum will feature motivating speakers and…
Join us for an intensive 3-day AUA Review Course featuring expert international speakers from the American Urological Association (AUA). This course is designed for urology…
Registration for the 2025 AUA Innovation Nexus Conference is now open! As you plan to attend this groundbreaking event, please review these key details. For…
The 2025 AUA Annual Meeting program will offer more education and innovative programming than ever before! Join us in Las Vegas.